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Apical hypertrophic cardiomyopathy is a form of
hypertrophic cardiomyopathy localized to the left
ventricular apex. The disease is common in Japanese
and other Asian populations but its presence has also
been recognized, though less commonly, in non-Asian
patients. Its prognosis is relatively benign in terms of
cardiovascular mortality but morbid sequelae, such as
diastolic dysfunction, left atrial enlargement, apical
thrombi, ventricular aneurysms, and myocardial infarc-
tion, may occur. In patients with apical hypertrophic
cardiomyopathy, the electrocardiographic changes and
symptoms associated often mimic acute coronary
syndromes. Invasive or noninvasive evaluation of the
left ventricular cavity conﬁrms the diagnosis of apical
hypertrophic cardiomyopathy, with the ‘‘ace-of-
spades’’ sign on left ventriculography being pathogno-
monic. It is therefore of utmost importance to use the
appropriate imaging modalities to establish the correct
diagnosis of apical hypertrophic cardiomyopathy. For
instance, using doppler-echocardiography in 182
patientswithapicalhypertrophiccardiomyopathy,three
morphologically distinct phenotypes i.e. (1) pure focal,
(2) pure diffuse, and (3) a mixed type according to
patternsofhypertrophycouldbediscerned[1].Detailed
subtypingturnedouttobeimportantinthepredictionof
development of atrial ﬁbrillation, left atrial volume
index and left ventricular longitudinal function.
In the current edition of this issue, Duygu et al. [2]
studied 17 patients with chest pain who had a pre-
diagnosis of coronary artery disease but a ﬁnal
diagnosis of apical hypertrophic cardiomyopathy.
Interestingly, all patients showed typical spade-like
appearance of the left ventricle by contrast ventricu-
lography and giant negative T-waves on the
electrocardiogram. Transthoracic echocardiography
showed a maximum wall thickness of 18 ± 4m m
and a mean gradient of 30 mmHg by Doppler echo-
cardiography. None of the patients showed signiﬁcant
coronary artery disease; four patients showed myocar-
dial bridging. The authors recommended that the
diagnosis of apical hypertrophic cardiomyopathy
should always be considered in certain patients with
typical anginal symptoms and outspoken negative T
waves on the electrocardiogram. As a result, physi-
cians caring for patients with chest pain should
consider apical hypertrophic cardiomyopathy in their
differential diagnosis in case of a patient with chest
pain and electrocardiographic changes suggestive of
coronary artery disease. Stated by the authors, these
patients should all undergo echocardiography to sep-
arate apical hypertrophic cardiomyopathy from acute
myocardial ischemia. Although the authors mention
that ischemic evaluation was not performed, they only
refer to thallium myocardial scintigraphy as potential
modality to identify ischemia in apical hypertrophic
cardiomyopathy. Indeed, myocardial scintigraphy
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shown to be useful in the evaluation of cardiomyop-
athies [3–6].
It is, however, noteworthy that the authors did not
refer to cardiac magnetic resonance imaging (CMR) as
an accurate and reliable means of evaluating cardiac
morphology, ventricular function, and myocardial per-
fusion,bothfor the left and the right ventricle therewith
covering a whole spectrum of cardiac diseases [7–12].
In particular, CMR is very well suited for identifying
and characterizing patients with hypertrophic cardio-
myopathy [13, 14]. For instance, Tsukamoto et al. [15]
showed systolic outward motion of the left ventricular
apical wall in patients with apical hypertrophic cardio-
myopathyusingCMRtagging.Inaddition,CMRallows
accurate evaluation of myocardial ischemia and infarc-
tionwith the potential toestablish thetransmuralextent
of myocardial infarction with high spatial resolution
[16–18]. Late gadolinium-enhanced CMR can clearly
delineatesubendocardialinfarctionandCMRappearsto
be more sensitive than other imaging methods in
detectingsmallinfarctsandischemia[19–21].Inrecent
years,lategadoliniumenhancementCMRhasalsobeen
usedtovisualizemyocardialinterstitialabnormalitiesin
patients with different forms of cardiomyopathies [22,
23]. In patients with apical hypertrophic cardiomyop-
athy, ﬁrst-pass gadolinium delayed-enhanced CMR
may show local delayed enhancement in the subendo-
cardium in the hypertrophic lesion. The presence of
perfusion defect and delayed enhancement may be a
marker of a high-risk patient with apical hypertrophic
cardiomyopathy [24]. On the other hand, patients with
apical hypertrophic cardiomyopathy may show focal
hyperenhancementofthenon-hypertrophicbasallateral
segment of the left ventricle, and absence of hyperen-
hancement of the hypertrophied apical segments [25].
It can be concluded that apical hypertrophic
cardiomyopathy is a disease that may mimic coronary
artery disease in a certain subset of patients. Hence,
adequate diagnostic methods are needed to distinguish
between these two entities. Although echocardiogra-
phy remains the ﬁrst line of investigation in these
patients the ﬁnal answer might be given by CMR.
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